Pharma/PBMs

An original author of the Affordable Care Act explores what the new federal push to lower prescription drug prices could do—and what it may be missing.

Employment law experts explore trends in health plan regulations that may shift as the new administration brings new priorities.

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the same path, this expert writes.

Employer health plans brace for ongoing soaring costs as GLP-1 utilization continues to rise. What trends are coming down the pike for HR?

That is the million-dollar question facing HR. Experts explore how trends in the use of GLP-1s for weight management are massively disrupting the benefits landscape.

The federal agency recently called out the nation's leading pharmacy benefit managers for inflating prices, driving up pharmacy costs for both employers and employees.